BMSLX
Price
$15.46
Change
-$0.03 (-0.19%)
Updated
Sep 20 closing price
VMCPX
Price
$352.79
Change
-$0.65 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

BMSLX vs VMCPX

Header iconBMSLX vs VMCPX Comparison
Open Charts BMSLX vs VMCPXBanner chart's image
MFS Blended Research Mid Cap Eq I
Price$15.46
Change-$0.03 (-0.19%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index InstitutionalPlus
Price$352.79
Change-$0.65 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
BMSLX vs VMCPX Comparison Chart
Loading...
VS
BMSLX vs. VMCPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMSLX is a StrongBuy and VMCPX is a Buy.

FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 172B vs. BMSLX (813M). VMCPX pays higher dividends than BMSLX: VMCPX (1.51) vs BMSLX (0.96). BMSLX was incepted earlier than VMCPX: BMSLX (8 years) vs VMCPX (14 years). BMSLX is a more actively managed with annual turnover of: 67.00 vs. VMCPX (13.00). BMSLX has a lower initial minimum investment than VMCPX: BMSLX (0) vs VMCPX (100000000). BMSLX annual gain was more profitable for investors over the last year : 31.03 vs. VMCPX (25.17). VMCPX return over 5 years is better than : 56.93 vs. BMSLX (33.20).
BMSLXVMCPXBMSLX / VMCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years14 years-
Gain YTD18.28612.593145%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets813M172B0%
Annual Yield % from dividends0.961.5164%
Returns for 1 year31.0325.17123%
Returns for 3 years1.249.8513%
Returns for 5 years33.2056.9358%
Returns for 10 yearsN/A128.75-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHR3.060.01
+0.33%
Archer Aviation
SBT4.64-0.02
-0.43%
Sterling Bancorp
EBAY62.75-0.47
-0.74%
eBay
CNXC63.38-0.79
-1.23%
Concentrix Corp
NRBO3.19-0.07
-2.15%
NeuroBo Pharmaceuticals